Table 3 Comparison of individuals who tested PCR negative versus individuals who tested PCR positive for SARS-CoV-2 infection* in the community survey conducted on May 6–7, 2020 with respect to presence of symptoms.
From: Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Reported symptoms | SARS-CoV-2 negative | SARS-CoV-2 positive | Univariable regression analysis | ||
|---|---|---|---|---|---|
N (%†) | N (%†) | p value | OR (95% CI)‡ | p value | |
Presence of symptoms | |||||
Asymptomatic | 764 (79.5) | 72 (58.5) | 0.003 | 1.00 | |
Symptomatic | 217 (20.5) | 61 (41.6) | 2.75 (1.39–5.45) | 0.004 | |
Overall | |||||
No symptoms | 764 (79.5) | 72 (58.5) | < 0.001 | 1.00 | |
One symptom | 119 (11.0) | 18 (14.9) | 1.84 (0.64–5.30) | 0.258 | |
Two symptoms | 59 (6.3) | 19 (8.5) | 1.84 (0.75–4.47) | 0.180 | |
Three or more symptoms | 39 (3.2) | 24 (18.1) | 7.73 (2.97–20.08) | < 0.001 | |
